FDA Clears Roche Point-of-Care STI Tests
The FDA granted 510(k) clearance for Roche STI multiplex panels, enabling rapid diagnosis of chlamydia, gonorrhea, and Mycoplasma genitalium.
Read MorePosted by Andy Lundin | Jan 22, 2025 | Point-of-Care, Sexually Transmitted Diseases |
The FDA granted 510(k) clearance for Roche STI multiplex panels, enabling rapid diagnosis of chlamydia, gonorrhea, and Mycoplasma genitalium.
Read MorePosted by Andy Lundin | Jan 15, 2025 | Covid 19, Point-of-Care |
The TwinDemic Detection system is a rapid and sensitive diagnostic tool that detects SARS-CoV-2 and influenza A virus simultaneously.
Read MorePosted by Andy Lundin | Jan 6, 2025 | Covid 19 |
Coordinated efforts in distributing COVID tests saved 1.4 million lives and prevented 7 million hospitalizations in the U.S.
Read MorePosted by Andy Lundin | Dec 17, 2024 | Point-of-Care |
A new nanobody-based immunosensor is capable of stable operation in undiluted biological fluids with promising applications in POC testing.
Read MorePosted by Andy Lundin | Nov 27, 2024 | Company News, Sepsis |
Trinity Biotech made a strategic investment in Novus Diagnostics to accelerate the development of a 15-minute bedside test for sepsis.
Read More